Hemics

company

About

Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA).

  • 1 - 10

Details

Last Funding Type
Series B
Industries
Health Care,Medical
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA). We aim at improving the quality of life of patients with RA by creating imaging devices that support the rheumatologist in monitoring and treatment of this disease.

Its devices are based on the patented Optical Inflammation Detection technology, a non-invasive, fast and objective method that supports rheumatologists in the quantification of inflammation, a key parameter in the treatment of patients with RA.

Hemics was founded as a spin-out of Royal Philips Electronics, where the Optical Inflammation Detection technology was invented.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Hemics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 9, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 9, 2015 Series B 1 DFZ Participaties Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Hemics is funded by 1 investors. DFZ Participaties are the most recent investors.
Investor Name Lead Investor Funding Round
DFZ Participaties Yes Series B